DY, C., WL, M., & YS, L. (2021). Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives. Dove Medical Press.
Style de citation Chicago (17e éd.)DY, Chang, Ma WL, et Lu YS. Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)DY, Chang, et al. Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives. Dove Medical Press, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.